Mutations in the SRY, DAX1, SF1 and WNT4 genes in Brazilian sex-reversed patients

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 1, 2004, Pages 145-150

  Domenice, S ^a   Correa, R V ^a   Costa, E M F ^a   Nishi, M Y ^a   Vilain, E ^a   Arnhold, I J P ^a   Mendonca, Beremen B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

DAX1 gene; Sex reversal; SF1 gene; SRY gene; WNT4 gene

Indexed keywords

HOMEODOMAIN PROTEIN; STEROIDOGENIC FACTOR 1; TRANSCRIPTION FACTOR; WNT PROTEIN;

ADRENAL INSUFFICIENCY; ARTICLE; BRAZIL; FEMALE; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE INACTIVATION; GENE INTERACTION; GENE MUTATION; GENE OVEREXPRESSION; GONAD DEVELOPMENT; HERMAPHRODITISM; HIGH MOBILITY GROUP BOX DOMAIN; HUMAN; MALE; MUTATIONAL ANALYSIS; PROTEIN DOMAIN; SEX DETERMINATION; SEX TRANSFORMATION; SRY GENE; TESTIS DEVELOPMENT; TRUE HERMAPHRODITISM;

MAMMALIA;

EID: 1242352080     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004000100020     Document Type: Article

References (32)

1. Berta P, Hawkins JR, Sinclair AH, Taylor A, Griffths BL, Goodfellow PN & Fellous M (1990). Genetic evidence equating SRY and the testis determinig factor. Nature, 348: 448-450.
2. Vilain E, McElreavey K, Vidaud M, Richaud F & Fellous M (1991). L'analyse cle SRY n'explique pas toute la pathologie du determinisme du sexe. Annales d'Endocrinologie, 52: 435-436.
3. Fechner PY, Marcantonio SM, Jaswaney V, Stetten G, Goodfelow PN, Migeon CJ, Smith KD & Berkovitz GD (1993). The role of the sex-determining region Y gene in the etiology of 46,XX maleness. Journal of Clinical Endocrinology and Metabolism, 76: 690-695.
4. Veitia RA, Salas-Cortés L, Ottolenghi C, Pailhoux E, Cotinot C & Fellous M (2001). Testis determination in mammals: more questions than answers. Molecular and Cellular Endocrinology, 179: 3-16.
5. Ahmed SF & Hughest IA (2002). The genetics of male undermasculinization. Clinical Endocrinology, 56: 1-18.
6. Boucekkine C, Toublanc JE, Abbas N et al. (1994). Clinical and anatomical spectrum in XX sex reversed patients. Relationship to the presence of Y specific DNA-sequences. Clinical Endocrinology, 40: 733-742.
7. Huang B, Wang S, Ning Y, Lamb AN & Bartley J (1999). Autosomal XX sex reversal caused by duplication of SOX9. American Journal of Medical Genetics, 87: 349-353.
8. Pelletier J, Bruening W, Li FP, Glaser T, Harber DA & Housman D (1991). WT1 mutations contribute to abnormal genital system development and hereditary Wilm's tumor. Nature, 353: 431-434.
9. Hawkins JR, Taylor A, Berta P, Levilliers J, Van der Auwera B & Goodfellow PN (1992). Mutational analysis of SRY: nonsense and missense mutations in XY sex reversal. Human Genetics, 88: 471-474,
10. Bardoni B, Zanaria E, Guoli S et al. (1994). A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nature Genetics, 7: 497-501.
11. Foster JW, Dominguez-Steglich MA, Guioli S et al. (1994). Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature, 372: 525-529.
12. Achermann JC, Ito M, Ito M, Hindmarsh PC & Jameson JL (1999). A mutation in the gene encoding steroidogenic factor 1 causes XY sex reversal and adrenal failure in humans. Nature Genetics, 22: 125-126 (Letter).
13. Raymond CS, Parker ED, Kettlewell JR et al. (1999). A region of human chromosome 9p required for testis development contains two genes related to known sexual regulators. Human Molecular Genetics, 8: 989-996.
14. Vainio S, Heikkila M, Kispert A, Chin N & McMahon AP (1999). Female development in mammals is regulated by Wnt-4 signalling. Nature, 397: 405-409.
15. Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf AM, Lovell-Badge R & Goodfellow PN (1990). A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif, Nature, 346: 240-246.
16. Hawkins JR, Taylor A, Goodfellow PN, Migeon CJ, Smith KD & Berkovitz GD (1992). Evidence for increased prevalence of SRY mutations in XY females with complete rather than partial gonadal dysgenesis. American Journal of Human Genetics, 51: 979-984.
17. Domenice S, Nishi MY, Billerbeck AEC et al. (1998). A novel missense mutation (S18N) in the 5′non-HMG box region of SRY gene in a patient with partial gonadal dysgenesis and his normal male relatives. Human Genetics, 102: 213-215.
18. Jäger RJ, Harley VR, Pfeiffer RA, Goodfellow PN & Scherrer GA (1992). A familial mutation in the sex determining gene SRY shared by both sexes. Human Genetics, 90: 350-355.
19. Vilain E, McElreavey K, Jaubert F, Raymond JP, Richaud F & Fellous M (1992). Familial case with sequence variant in the testis determining region associated with two sex phenotypes. American Journal of Human Genetics, 50: 1008-1011.
20. Zenteno-Ruiz JC, Kofman-Alfaro S & Mendez JP (2001). 46,XX sex reversal, Archives of Medical Research, 32: 559-566.
21. Kusz K, Kotecki M, Wodja A, Szarras-Czapnik M, Latos-Bielenska A, Warenik-Szymankiewiccs A, Ruszczynska-Wolska A & Jaruzelska J (1999). Incomplete masculinization of XX subjects carrying the SRY gene on an inactive X chromosome. Journal of Medical Genetics, 36: 452-456.
22. Domenice S, Nishi MY, Billerbeck AEC, Carvalho FM, Frade EMC, Latronico AC, Arnhold IJP & Mendonca BB (2001). Molecular analysis of SRY gene in Brazilian 46,XX sex-reversed patients: absence of SRY sequence in gonadal tissue. Medical Science Monitor (http://www.msi.com.pl), 7: 238-241.
23. McElreavey K, Vilain E, Abbas N, Herskowitz I & Fellous M (1993). A regulatory cascade hypothesis for mammalian sex determination: SRY represses a negative regulator of male development. Proceedings of the National Academy of Sciences, USA, 90: 3368-3372.
24. Guo W, Burris TP, Zhang YH, Huang BL, Mason J, Copeland KC, Kupfer SR, Pagon RA & McCabe ERB (1996). Genomic sequence of the DAX-1 gene: An orphan nuclear receptor responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism, 81: 2481-2486,
25. Yu RN, Achermann JC, Ito M & Jameson JL (1998). The role of DAX-1 in reproduction. Trends of Endocrinology and Metabolism, 9: 169-175.
26. Kolon TF, Ferrer FA & McKenna PH (1998). Clinical and molecular analysis of XX sex reversed patients. Journal of Urology, 160: 1169-1172.
27. Swain A, Narvaez V, Burgoyne P, Camerino G & Lovell-Badge R (1998). Dax1 antagonizes Sry action in mammalian sex determination. Nature, 391: 761-767.
28. Parker KL & Schimmer BP (1997). Steroidogenic factor 1: a key determinant of endocrine development and function. Endocrine Reviews, 18: 361-377.
29. Biason-Lauber A & Schoenle EJ (2000). Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF1) and adrenocortical insufficiency. American Journal of Human Genetics, 67: 1563-1568.
30. Achermann JC, Ozisik G, Ito M, Orun UA, Harmanci K, Gurakan B & Jameson JL (2002). Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. Journal of Clinical Endocrinology and Metabolism 87: 1829-1833.
31. Stark K, Vainio S, Vassileva G & McMahon AP (1994). Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt4. Nature, 372: 679-683.
32. Jordan BK, Mohammed M, Ching ST, Delot E, Chen XN, Dewing P, Swain A, Rao N, Elejalde BR & Vilain E (2001). Up regulation of WNT4 signaling and dosage sensitive sex reversal in humans. American Journal of Human Genetics, 68: 1102-1109.